Danon disease: A novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression

Claudia Di Blasi, Laura Jarre, Flavia Blasevich, Patrizia Dassi, Marina Mora

Research output: Contribution to journalArticle

Abstract

LAMP2, the causative gene of Danon disease, located on chromosome Xq24, encodes the lysosome-associated membrane protein-2 (LAMP-2). We describe clinical features and molecular data in an Italian patient with Danon disease. The patient had hyperCKemia, hypertrophic cardiomyopathy, no muscle weakness and slight mental impairment. Muscle biopsy revealed autophagic vacuoles with sarcolemmal features and glycogen storage. Immunohistochemistry and immunoblot revealed traces of LAMP-2 protein in skeletal muscle. Molecular analysis of the LAMP2 gene revealed a novel hemizygous mutation affecting the invariant +1 position of the splice site of intron 8, resulting in aberrant transcripts with skipping of exon 8 in all three LAMP-2 isoforms, skipping of exons 7 and 8 in LAMP-2A and 2C, and a 15 bp deletion in exon 8 of LAMP-2B. Low levels of normal LAMP-2B transcript were also present. Danon disease is an under-recognized and frequently fatal condition, treatable by heart transplantation. Investigation of the primary molecular defect is important for cardiac surveillance and genetic counseling.

Original languageEnglish
Pages (from-to)962-966
Number of pages5
JournalNeuromuscular Disorders
Volume18
Issue number12
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Glycogen Storage Disease Type IIb
Lysosome-Associated Membrane Glycoproteins
RNA Precursors
Exons
Mutation
Proteins
Hypertrophic Cardiomyopathy
Muscle Weakness
Genetic Counseling
Heart Transplantation
Vacuoles
Glycogen
Introns
Genes
Protein Isoforms
Skeletal Muscle
Chromosomes
Immunohistochemistry
Biopsy
Muscles

Keywords

  • Danon disease
  • Exon skipping
  • LAMP2
  • Lysosomal membrane proteins
  • Lysosomal storage disease

ASJC Scopus subject areas

  • Genetics(clinical)
  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology

Cite this

Danon disease : A novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression. / Di Blasi, Claudia; Jarre, Laura; Blasevich, Flavia; Dassi, Patrizia; Mora, Marina.

In: Neuromuscular Disorders, Vol. 18, No. 12, 12.2008, p. 962-966.

Research output: Contribution to journalArticle

Di Blasi, Claudia ; Jarre, Laura ; Blasevich, Flavia ; Dassi, Patrizia ; Mora, Marina. / Danon disease : A novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression. In: Neuromuscular Disorders. 2008 ; Vol. 18, No. 12. pp. 962-966.
@article{a00c91d8b8874feda00ef8d561acd0a3,
title = "Danon disease: A novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression",
abstract = "LAMP2, the causative gene of Danon disease, located on chromosome Xq24, encodes the lysosome-associated membrane protein-2 (LAMP-2). We describe clinical features and molecular data in an Italian patient with Danon disease. The patient had hyperCKemia, hypertrophic cardiomyopathy, no muscle weakness and slight mental impairment. Muscle biopsy revealed autophagic vacuoles with sarcolemmal features and glycogen storage. Immunohistochemistry and immunoblot revealed traces of LAMP-2 protein in skeletal muscle. Molecular analysis of the LAMP2 gene revealed a novel hemizygous mutation affecting the invariant +1 position of the splice site of intron 8, resulting in aberrant transcripts with skipping of exon 8 in all three LAMP-2 isoforms, skipping of exons 7 and 8 in LAMP-2A and 2C, and a 15 bp deletion in exon 8 of LAMP-2B. Low levels of normal LAMP-2B transcript were also present. Danon disease is an under-recognized and frequently fatal condition, treatable by heart transplantation. Investigation of the primary molecular defect is important for cardiac surveillance and genetic counseling.",
keywords = "Danon disease, Exon skipping, LAMP2, Lysosomal membrane proteins, Lysosomal storage disease",
author = "{Di Blasi}, Claudia and Laura Jarre and Flavia Blasevich and Patrizia Dassi and Marina Mora",
year = "2008",
month = "12",
doi = "10.1016/j.nmd.2008.09.008",
language = "English",
volume = "18",
pages = "962--966",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Ltd",
number = "12",

}

TY - JOUR

T1 - Danon disease

T2 - A novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression

AU - Di Blasi, Claudia

AU - Jarre, Laura

AU - Blasevich, Flavia

AU - Dassi, Patrizia

AU - Mora, Marina

PY - 2008/12

Y1 - 2008/12

N2 - LAMP2, the causative gene of Danon disease, located on chromosome Xq24, encodes the lysosome-associated membrane protein-2 (LAMP-2). We describe clinical features and molecular data in an Italian patient with Danon disease. The patient had hyperCKemia, hypertrophic cardiomyopathy, no muscle weakness and slight mental impairment. Muscle biopsy revealed autophagic vacuoles with sarcolemmal features and glycogen storage. Immunohistochemistry and immunoblot revealed traces of LAMP-2 protein in skeletal muscle. Molecular analysis of the LAMP2 gene revealed a novel hemizygous mutation affecting the invariant +1 position of the splice site of intron 8, resulting in aberrant transcripts with skipping of exon 8 in all three LAMP-2 isoforms, skipping of exons 7 and 8 in LAMP-2A and 2C, and a 15 bp deletion in exon 8 of LAMP-2B. Low levels of normal LAMP-2B transcript were also present. Danon disease is an under-recognized and frequently fatal condition, treatable by heart transplantation. Investigation of the primary molecular defect is important for cardiac surveillance and genetic counseling.

AB - LAMP2, the causative gene of Danon disease, located on chromosome Xq24, encodes the lysosome-associated membrane protein-2 (LAMP-2). We describe clinical features and molecular data in an Italian patient with Danon disease. The patient had hyperCKemia, hypertrophic cardiomyopathy, no muscle weakness and slight mental impairment. Muscle biopsy revealed autophagic vacuoles with sarcolemmal features and glycogen storage. Immunohistochemistry and immunoblot revealed traces of LAMP-2 protein in skeletal muscle. Molecular analysis of the LAMP2 gene revealed a novel hemizygous mutation affecting the invariant +1 position of the splice site of intron 8, resulting in aberrant transcripts with skipping of exon 8 in all three LAMP-2 isoforms, skipping of exons 7 and 8 in LAMP-2A and 2C, and a 15 bp deletion in exon 8 of LAMP-2B. Low levels of normal LAMP-2B transcript were also present. Danon disease is an under-recognized and frequently fatal condition, treatable by heart transplantation. Investigation of the primary molecular defect is important for cardiac surveillance and genetic counseling.

KW - Danon disease

KW - Exon skipping

KW - LAMP2

KW - Lysosomal membrane proteins

KW - Lysosomal storage disease

UR - http://www.scopus.com/inward/record.url?scp=56649112836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56649112836&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2008.09.008

DO - 10.1016/j.nmd.2008.09.008

M3 - Article

C2 - 18990578

AN - SCOPUS:56649112836

VL - 18

SP - 962

EP - 966

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 12

ER -